Probing the cardioprotective effects of sulfane sulfurs with next generation fluorescent sensors
使用下一代荧光传感器探讨硫烷硫的心脏保护作用
基本信息
- 批准号:10749202
- 负责人:
- 金额:$ 4.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-01 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdvanced DevelopmentAnimal ModelAutophagocytosisAwardBiologicalBiological AssayBiological AvailabilityBiological MarkersBiological ModelsBiological PhenomenaBiologyBloodCardiacCardiovascular DiseasesCardiovascular PathologyCardiovascular systemCell modelCellsCellular biologyChemicalsClinicalComplexConfocal MicroscopyDataData ScienceDetectionDevelopmentDiagnosticDiseaseEducational process of instructingEnvironmentEvaluationExhibitsExposure toFellowshipFlow CytometryFluorescenceFluorescence MicroscopyFluorescent DyesFutureGoalsHealthHeart DiseasesHeart failureHomeostasisHydrogen SulfideIn VitroIndividualInstitutionKnowledgeLasersLeadershipLiquid substanceMachine LearningMapsMediatingMethodsModificationMolecular BiologyMyocardial IschemiaMyocardial Reperfusion InjuryOrganellesOrganic ChemistryOrganic SynthesisOxidantsOxidation-ReductionOxidative StressPathway interactionsPlasmaPositioning AttributeProceduresProtocols documentationRecording of previous eventsReperfusion TherapyRoleSignaling MoleculeSincalideSpecificitySulfurSystemTestingTherapeuticTissuesTrainingTubeUniversitiesWorkbiological systemscardioprotectioncardiovascular disorder therapycareercertificate programcombatcommercializationcytotoxicitydesigndetection methoddiagnostic toolethnic disparityfluorophoregender disparityhuman diseaseimprovednear infrared dyenext generationnoveloutreachoxidative damagepreventprofessorquantumratiometricresponsesensorskillssymposiumtherapeutic targetthioestertool
项目摘要
Project Summary
Redox imbalances of reactive sulfur species (RSS) in cardiac cells contribute to
cardiovascular diseases such as myocardial ischemia-reperfusion (MI/R) injury and heart failure.
Applications of sulfane sulfurs have been found to cause cardioprotective effects, and sulfane
sulfur bioavailability in plasma has even been recently suggested to be a biomarker for
cardiovascular disease (CVD). However, this field currently lacks clear understandings as to how
endogenous RSS, particularly sulfane sulfurs, work. Our long-term goal is to elucidate the
complex sulfane sulfur pathways at various health stages of cardiac cells and use this information
to drive the development of early diagnostic tools and therapies for CVD. Specifically, this project
will meet the critical need of having effective methods to study these pathways by developing
chemical tools that: 1) quantifiably ‘see into cells/tissues’ despite the presence of biological fluids
such as blood and 2) turn-on only after subcellular localization. These highly sensitive, specific,
and targetable/triggerable next generation fluorescent sensors will allow us to probe the
cardioprotective roles of sulfane sulfurs in cardiac cell models of MI/R injury even to subcellular
extents and non-invasively decipher complex cardiovascular sulfur-mediated redox pathways. We
expect that: 1) promising sensors will be identified for future evaluations in animal models of MI/R
and 2) our tools and studies will establish a strong basis for advancing the clinical potential of
sulfane sulfurs through a greater understanding of the mechanisms by which sulfane sulfurs
regulate redox environments in CVD. The long-term goal for this fellowship award is to develop
essential skills for a successful career as a chemical biology professor studying human diseases
at an R1 institution. A team consisting of the sponsor and collaborators has been assembled with
expertise in organic chemistry and synthesis, redox biology, chemical biology, molecular and cell
biology, computational/data sciences, and cardiovascular diseases. Further training will be
obtained from conference attendance and presentations in conjunction with teaching certificate
programs, outreach, and leadership positions at Brown University.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Meg Shieh其他文献
Meg Shieh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
- 批准号:
10935820 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
- 批准号:
10932514 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
- 批准号:
10704845 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
- 批准号:
10709085 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10409385 - 财政年份:2022
- 资助金额:
$ 4.77万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10710595 - 财政年份:2022
- 资助金额:
$ 4.77万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10630975 - 财政年份:2022
- 资助金额:
$ 4.77万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
- 批准号:
10710588 - 财政年份:2022
- 资助金额:
$ 4.77万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10788051 - 财政年份:2022
- 资助金额:
$ 4.77万 - 项目类别: